554
Participants
Start Date
October 31, 2006
Primary Completion Date
June 30, 2010
Study Completion Date
August 31, 2011
Teplizumab
Daily IV dosing for 14 days, repeated at Week 26
Placebo
Daily IV dosing for 14 days, repeated at Week 26
P. Stradins Clinical University Hospital, Riga
Hospital Clinic I Provincial, Barcelona
Hospital Germans Trias i Pujol, Badalona
FN Kralovske Vinohrady, Prague
Schneider Children's Hospital, New Hyde Park
Sodersjukhuset AB, Stockholm
Charité-Hochschulmedizin Berlin, Berlin
Albany Medical Center, Albany
Joslin Diabetes Center, Syracuse
Hospital Universitari Dr. Josep Trueta de Girona, Girona
St. Mary Medical Center, Langhorne
Christiana Care Research Institute, Newark
"Centrul Medical Sanatatea ta", Bucharest
Maryland Diabetes & Endocrine Associates, Rockville
Regional Clinical Endocrinological Dispensary, Vinnitsa
St. Agnes Hospital, Baltimore
Universitetssjukhuset i Lund, Lund
Fundacion Jimenez Diaz, Madrid
Hospital Universitario Principe de Asturias, Alcalá de Henares
Sumter Medical Specialists, Sumter
Atlanta Diabetes Associates, Atlanta
Rambam Medical Centre, Haifa
Herz-und Diabetszentrum Nordrhein-Westfalen, Bad Oeynhausen
Richard Hays, MD, Wellington
UAB School of Medicine, Birmingham
Universitatsklinik Giessen, Giessen
University Diabetes & Endocrine Consultants, Chattanooga
Hillel Yaffe Medical Center, Hadera
Methodist Healthcare, Memphis
Masarykova nemocnice v Usti nad Labem, Ústí nad Labem
Commonwealth Biomedical Research, LLC, Madisonville
Cleveland Clinic, Cleveland
Hospital Mexico-Americano, Guadalajara
Riley Hospital for Children, Indianapolis
Alzohaili Medical Consultants, Dearborn
National Centre for Childhood and Diabetes, Petah Tikva
FN Hradec Kralove, Hradec Králové
Tartu University Hospital, Puusepa
Medical College of Wisconsin, Milwaukee
Chaim Sheba Medical Center, Ramat Gan
Powiatowy Zespot Szpitali w Olesnicy, Oddzial Chorob Wewnetrznych, Oleśnica
Wolfson Medical Centre, Holon
Universitetssjukhuset i Linkoping, Linköping
Nemocnice Jihlava, Jihlava
V. Danilevsky Institute of Endocrine Pathology Problems, Kharkiv
Kharkiv Regional Clinical Children's Hospital, Kharkiv
FN Brno- Detska nemocnice, Brno
The Children's Mercy Hospital, Kansas City
Hospital CIMA Santa Engracia, San Pedro Garza García
Mid-America Diabetes Associates, PA, Wichita
Creighton Diabetes Center, Omaha
Zaporizhzhya Regional Pediatric Hospital, Zaporizhzhya
Universitätsklinikum Heidelberg, Heidelberg
Arkansas Children's Hospital, Little Rock
NEA Clinic, Jonesboro
Research Institute of Dallas, Dallas
Diabetes and Glandular Disease Research, San Antonio
Hospital Central, San Luis Potosí City
Spectra Research Center, McAllen
University of Colorado Health Sciences Center, Aurora
Donetsk Regional Children Clinical Hospital, Donetsk
Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls
Soroka Medical Centre, Beersheba
Endocrine Research Specialists, Ogden
Humphrey Diabetes Center, Boise
Medizinische Universitätsklinik Ulm, Ulm
Diabetes Medical Center of California, Northridge
I. Szpital Miejski im. Dr. E. Sonnenberga w Lodzi, Lodz
UCSF Medical Center, San Francisco
Pacific Northwest Research Institute, Seattle
Pushpawati Singhania Research Institute, New Delhi
Bharti Research Institute of Diabetes & Endocrinology, Karnāl
Fortis Escorts Hospital, Jaipur
Gujarat Endocrine Centre, Ahmedabad
DHL Research Centre, Ahmedabad
Spitulul Clinic Judetean de Urgenta Cluj, Cluj-Napoca
Diabetes Action Centre, Mumbai
Grant Medical Foundation, Pune
Endocrine Clinic, Nashik
Gandhi Endocrinology and Diabetes Centre, Nagpur
Spitalul Judetean Satu Mare, Satu Mare
Diabetes Thyroid Hormone Research Institute PVT LTD, Indore
Medwin Hospitals, Hyderabad
Nizam's Institute of Medical Sciences, Hyderabad
King George Hospital, Visakhapatnam
Bangalore Diabetes Centre, Bangalore
S.C. Minimed S.R.L., Bacau
B.P.Poddar Hospital and Medical Research Ltd, Kolkata
Spitalul Clinic Judetean de Urgenta, Iași
Yale University, New Haven
University of Iowa Children's Hospital, Iowa City
Massachusetts General Hospital, Boston
Baystate Medical Center, Springfield
Saint Barnabas Medical Center, Livingston
University of Medicine & Dentistry of NJ, New Brunswick
Alberta Children's Hospital, Calgary
University of Manitoba, Winnipeg
University Health Sciences Centre, St. John's
Capital District Health Authority, Halifax
Oxford AIM Clinic, London
Children's Hospital of Western, London
Fakultni nemocnice v Motole, Prague
East Tallinn Central Hospital, Tallinn
Hospital General de Mexico, Mexico City
Diabeter Center for Pediatric and Adolescent Diabetes Care and Research, Rotterdam
Samodzielny Publiczny Szpital Kliniczny Akademi Medycznej w Bialymstoku, Bialystok
Oddzial Diabetologiczny Klinika Pediatrii, Gdansk
Wojewodzki Specjalistyczny Szpital Dzieciecy, Kielce
Uniwersytecki Szpital Kliniczny, Lodz
Klinika Endokrynologii i Diabetologii Wieku Rozwojowego, Wroclaw
Institutul de Diabet, Bucharest
Ukrainian Scientific and Practical Center of Endocrine Surgery, Kyiv
Ukranian Children Specialised Clinical Hospital, Kyiv
Addenbrookes Hospital, Cambridge
Royal Devon and Exeter Hospital, Exeter
Lead Sponsor
Eli Lilly and Company
INDUSTRY
MacroGenics
INDUSTRY